Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13714112 | 1.00 | POLB (0.41) | POLBGAACHRM2CHRM1KMT2A | |
| SCHEMBL17836876 | 0.87 | CHRM2 (0.33) | POLBGAACHRM2CHRM1KMT2A | |
| SCHEMBL18604001 | 0.87 | CHRM2 (0.33) | POLBGAACHRM2CHRM1KMT2A | |
| SCHEMBL114981 | 0.87 | CHRM2 (0.33) | POLBGAACHRM2CHRM1KMT2A | |
| SCHEMBL15347376 | 0.85 | POLB (0.38) | POLBGAA | |
| SCHEMBL1627945 | 0.83 | POLB (0.38) | POLBGAA | |
| SCHEMBL1427774 | 0.83 | POLB (0.41) | POLBGAACHRM2CHRM1KMT2A | |
| SCHEMBL29564894 | 0.83 | POLB (0.38) | POLBGAA | |
| SCHEMBL29487239 | 0.83 | POLB (0.38) | POLBGAA | |
| SCHEMBL30879543 | 0.83 | POLB (0.38) | POLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 679 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608360-A1 | ANTI-DANDRUFF COMPOSITIONS | Firmenich SA (CH) | 2025-09-03 | — | — | EP | claimed |
| US-12338225-B2 | 2,2,6-trimethyl-4,5-dihydro-3H-oxepine as aroma ingredient | BASF SE (DE) | 2025-06-24 | — | — | US | claimed |
| US-20250092331-A1 | COMPOSITIONS COMPRISING 4-ISOPROPYL-1-METHYL-7-OXABICYCLO[2.2.1]HEPTAN-2-OL OR ESTERS OR ETHERS THEREOF AND THEIR USE AS AROMA CHEMICALS | BASF SE (DE) | 2025-03-20 | — | — | US | claimed |
| EP-4519404-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | Firmenich SA (CH) | 2025-03-12 | — | — | EP | claimed |
| CN-119403908-A | Method for enhancing psychological performance and composition for use in the method | 弗门尼舍有限公司 | 2025-02-07 | — | — | CN | claimed |
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | claimed |
| US-20240240106-A1 | 1,4-BUTANEDIOL MONO- OR DIESTERS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2024-07-18 | — | — | US | claimed |
| WO-2024133645-A1 | ANTI-DANDRUFF COMPOSITIONS | FIRMENICH SA (CH) | 2024-06-27 | — | — | WO | claimed |
| WO-2024115594-A1 | ACETIC ACID FOR INTENSIFYING OR MODIFYING THE AROMA OF AROMA CHEMICALS | BASF SE (DE) | 2024-06-06 | — | — | WO | claimed |
| WO-2024100254-A1 | DIMETHYL ACRYLIC ACID-BASED COMPOUNDS AS AROMA INGREDIENTS | BASF SE (DE) | 2024-05-16 | — | — | WO | claimed |
| WO-2005103214-A2 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2005-11-03 | — | — | WO | claimed |
| EP-1481049-A1 | MALODOR COUNTERACTING COMPOSITION | Symrise GmbH & Co. KG (DE) | 2004-12-01 | — | — | EP | claimed |
| US-6737395-B1 | APPLYING PERFUMES TO SKIN CAPABLE OF INACTIVATING CORYNE-BACTERIA | QUEST INTERNATIONAL B.V. (NL) | 2004-05-18 | — | — | US | claimed |
| US-6727221-B1 | APPLYING TO HUMAN SKIN A PERFUME COMPOSITION COMPRISING AT LEAST 50% BY WEIGHT OF PERFUME COMPONENTS HAVING A MINIMUM INHIBITORY CONCENTRATION (MIC) FOR CORYNEFORM BACTERIA OF GREATER THAN 0.1% | QUEST INTERNATIONAL B.V. (NL) | 2004-04-27 | — | — | US | claimed |
| EP-1094784-B1 | PERFUME COMPOSITION | QUEST INT (NL) | 2004-02-11 | — | — | EP | claimed |
| WO-2003070871-A1 | MALODOR COUNTERACTING COMPOSITION | SYMRISE GMBH & CO. KG (DE) | 2003-08-28 | — | — | WO | claimed |
| EP-1094784-A1 | PERFUME COMPOSITION | QUEST INTERNATIONAL B.V. (NL) | 2001-05-02 | — | — | EP | claimed |
| EP-1093355-A1 | METHOD OF REDUCING OR PREVENTING MALODOUR | QUEST INTERNATIONAL B.V. (NL) | 2001-04-25 | — | — | EP | claimed |
| WO-2000001352-A1 | PERFUME COMPOSITION | QUEST INTERNATIONAL B.V. (NL) | 2000-01-13 | — | — | WO | claimed |
| WO-2000001356-A1 | METHOD OF REDUCING OR PREVENTING MALODOUR | QUEST INTERNATIONAL B.V. (NL) | 2000-01-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12338225-B2 | 2,2,6-trimethyl-4,5-dihydro-3H-oxepine as aroma ingredient | DRD4, HTR5A, HTR4 | POLB 1596/4885GAA 4197/4885CHRM2 136/4885 |
| US-20250092331-A1 | COMPOSITIONS COMPRISING 4-ISOPROPYL-1-METHYL-7-OXABICYCLO[2.2.1]HEPTAN-2-OL OR ESTERS OR ETHERS THEREOF AND THEIR USE AS AROMA CHEMICALS | OXER1, MSMO1, IPO7 | POLB 1457/4885GAA 4652/4885CHRM2 1746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.